ARRZX
Price
$12.19
Change
-$0.11 (-0.89%)
Updated
Jun 22 closing price
Net Assets
43.38M
VEXAX
Price
$182.72
Change
-$0.22 (-0.12%)
Updated
Jun 22 closing price
Net Assets
93.74B
Interact to see
Advertisement

ARRZX vs VEXAX

ARRZX vs VEXAX Comparison Chart in %
View a ticker or compare two or three
VS
ARRZX vs. VEXAX commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARRZX is a Hold and VEXAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXAX has more cash in the bank: 93.7B vs. ARRZX (43.4M). ARRZX pays higher dividends than VEXAX: ARRZX (1.09) vs VEXAX (1.02). ARRZX was incepted earlier than VEXAX: ARRZX (9 years) vs VEXAX (26 years). ARRZX (0.97) is less costly to investors than VEXAX (0.05). ARRZX is a more actively managed with annual turnover of: 92.00 vs. VEXAX (12.00). VEXAX has a lower initial minimum investment than ARRZX: VEXAX (3000) vs ARRZX (5000000). VEXAX annual gain was more profitable for investors over the last year : 29.51 vs. ARRZX (-8.57). VEXAX return over 5 years is better than : 30.46 vs. ARRZX (-13.52).
ARRZXVEXAXARRZX / VEXAX
Total Expense Ratio0.780.051,560%
Annual Report Gross Expense Ratio0.970.051,940%
Fund Existence9 years26 years-
Gain YTD-5.89115.435-38%
Front LoadN/AN/A-
Min. Initial Investment50000003000166,667%
Min. Initial Investment IRAN/AN/A-
Net Assets43.4M93.7B0%
Annual Yield % from dividends1.091.02107%
Returns for 1 year-8.5729.51-29%
Returns for 3 years6.4369.519%
Returns for 5 years-13.5230.46-44%
Returns for 10 yearsN/A199.70-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSIQX7.04N/A
N/A
Morgan Stanley Inst International Eq I
DBMYX24.44N/A
N/A
BNY Mellon Sm/Md Cp Gr Y
TRZRX19.58N/A
N/A
T. Rowe Price Real Assets Z
NASDX54.55-0.09
-0.16%
Shelton Nasdaq-100 Index Investor
IOEZX19.85-0.05
-0.25%
ICON Equity Income Institutional